Literature DB >> 173489

Effect of oral contraceptives on plasma clearance.

D E Carter, R Bressler, M R Hughes, M R Haussler, D Christian, M W Heine.   

Abstract

The effects of chronic steroid contraceptive therapy on drug clearance from plasma were studied by using plasma antipyrine, phenylbutazone, and cholecalciferol half-lives in women. After 3 mo of oral steroid therapy (Norinyl, 2 mg; norethindrone + mestranol), the antipyrine half-life was increased in 3 of 6 subjects, phenylbutazone half-life was not consistently altered, and vitamin D3 half-life was increased in 3 of 4 patients. After 1 to 7 yr of oral steroid theraphy, the antipyrine half-life was longer while taking the contraceptive than when the contraceptive treatment was discontinued in 4 of 6 subjects, whereas that of phenylbutazone was not consistently altered.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173489     DOI: 10.1002/cpt1975186700

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Chronopharmacokinetics of ethanol. II. Circadian rhythm in rate of blood level decline in a single subject.

Authors:  F M Sturtevant; R P Sturtevant; L E Scheving; J E Pauly
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000

Review 2.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

3.  Effects of tobacco smoking and oral contraceptive use on theophylline disposition.

Authors:  M J Gardner; K M Tornatore; W J Jusko; R Kanarkowski
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

4.  Influence of sex, menstrual cycle and oral contraception on the disposition of nitrazepam.

Authors:  R Jochemsen; M van der Graaff; J K Boeijinga; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

5.  Metoprolol pharmacokinetics and the oral contraceptive pill.

Authors:  M J Kendall; C P Quarterman; D B Jack; L Beeley
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

6.  Effect of ticlopidine treatment on liver metabolizing enzymes in man.

Authors:  J J Thebault; C Blatrix; J Blanchard; E Panak
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

7.  Urinary D-glucaric acid and oral contraceptives.

Authors:  P M Stevens; C W Vose; R F Palmer
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

8.  Drug stimulated biotransformation of hormonal steroid contraceptives: clinical implications.

Authors:  E Hempel; W Klinger
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

Review 9.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

10.  Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.

Authors:  D M Chambers; G C Jefferson; M Chambers; N B Loudon
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.